Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
The Journal of Pathology|October 30, 2020
The protective effect of fibroblast growth factor-21 in alcoholic cardiomyopathy: a role in protecting cardiac mitochondrial functionGemma Ferrer-Curriu, Mariona Guitart-Mampel, Celia Rupérez, et al.International Journal of Cardiology. Heart & Vasculature|August 9, 2017
Ischemic postconditioning of the isolated human myocardium: Role of the applied protocolKelly Casós, María-Llanos Pérez, Arnau Blasco-Lucas, et al.The Journal of Pathology|December 25, 2018
Fibroblast growth factor-21 protects against fibrosis in hypertensive heart diseaseGemma Ferrer-Curriu, Ibon Redondo-Angulo, Mariona Guitart-Mampel, et al.Revista Espanola De Cardiologia (English Ed.)|April 27, 2023
Meteorin-like protein is associated with a higher risk profile and predicts a worse outcome in patients with STEMIGemma Ferrer-Curriu, Ferran Rueda, Elena Revuelta-López, et al.Plos One|April 6, 2017
Response of the human myocardium to ischemic injury and preconditioning: The role of cardiac and comorbid conditions, medical treatment, and basal redox statusKelly Casós, Gemma Ferrer-Curriu, Paula Soler-Ferrer, et al.The Journal of Experimental Medicine|February 26, 2021
Meteorin-like/Meteorin-β protects heart against cardiac dysfunctionCelia Rupérez, Gemma Ferrer-Curriu, Aina Cervera-Barea, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 10, 2022
Preclinical scenario of targeting myocardial fibrosis with chimeric antigen receptor (CAR) immunotherapyGemma Ferrer-Curriu, Carolina Soler-Botija, Sandra Charvatova, et al.European Journal of Medical Genetics|January 26, 2020
A single nucleotide deletion resulting in a frameshift in exon 4 of TAB2 is associated with a polyvalular syndromeEduard Permanyer, Steven Laurie, Arnau Blasco-Lucas, et al.Cells|December 24, 2021
Deep Learning Analyses to Delineate the Molecular Remodeling Process after Myocardial InfarctionOriol Iborra-Egea, Carolina Gálvez-Montón, Cristina Prat-Vidal, et al.The Journal of Pathology|August 31, 2023
A new FGF15/19-mediated gut-to-heart axis controls cardiac hypertrophySamantha Morón-Ros, Albert Blasco-Roset, Artur Navarro-Gascon, et al.Pageof 2